Phathom制药公司维持2026财年业绩指引,预计自第三季度起实现运营盈利

美股速递
Apr 30

Phathom Pharmaceuticals Inc(简称:Phathom制药)近日宣布,公司决定维持其2026财年的全年业绩指引不变。与此同时,该公司预计将从2026年第三季度开始实现运营层面的盈利。

这一预期标志着公司发展的重要转折点,表明其核心业务已具备持续产生正向现金流的能力。管理层对实现这一里程碑充满信心,反映出公司战略执行的有效性与市场对其产品需求的积极前景。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10